Endocrinology

Top Story

FDA approves CV event risk reduction indication for icosapent ethyl

December 13, 2019
Meeting NewsPerspective

Menopausal hormone therapy regimens have opposite lasting effects on breast cancer incidence

December 13, 2019
SAN ANTONIO — Two common hormone therapy regimens had opposite long-term effects on breast cancer incidence among postmenopausal women, according to results from…
FDA NewsPerspective

FDA authorizes marketing of first interoperable insulin dosing controller

December 13, 2019
The FDA on Friday authorized marketing of the Tandem Diabetes Care Control-IQ interoperable, automated insulin dosing algorithm, the first dosing controller that can be…
FDA News

FDA committee unanimously recommends approval of teprotumumab for thyroid eye disease

December 13, 2019
The Dermatologic and Ophthalmic Drugs Advisory Committee of the FDA voted 12-0 Friday in favor of recommending approval of a biologics license application for…

EMPERIAL top-line results: Empagliflozin for HFpEF, HFrEF fails to improve exercise ability

December 13, 2019
Boehringer Ingelheim and Eli Lilly and Co. announced negative top-line results for its EMPERIAL-Reduced and EMPERIAL-Preserved trials, nothing that the SGLT2 inhibitor…
More Headlines »
CME ABIM MOC

Ace the Case: A 70-Year-Old Woman With a 25-Year History of Type 2 Diabetes Mellitus and an Elevated A1C

No commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 70-year-old woman with a 25-year…
More »
Video
Meeting News

VIDEO: Canagliflozin protects kidney function across GFR-spectrum

November 11, 2019
More »
Resource Centers
ObesityWeek

ObesityWeek

CME ABIM MOC

Ace the Case: A 19-Year-Old Man With Uncontrolled Type 1 Diabetes Mellitus

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 19-year-old man with uncontrolled…
More »
Current Issues
View the Current Issue